RxDoctor Payments Data

Michael Gross, MD

Psychiatry · Rockville, MDNPI 1265653331

Payments from drug & device makers

$641in general payments, 2019–2025

Across 51 payments — averaging $12.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$401
  • Vanda Pharmaceuticals Inc.$66
  • Sunovion Pharmaceuticals Inc.$59
  • Bausch Health US, LLC$36
  • Johnson & Johnson$32
  • Axonics, Inc.$24
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$61195%
  • Education$305%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$641 in reported general payments places this provider in the 70th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$83,226
Medicare patients
61
Services billed
983

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate31$66,974
CaplytaLumateperone Tosylate28$63,958
VraylarCariprazine Hcl15$35,786
Wellbutrin XlBupropion Hcl12$22,431
BelsomraSuvorexant23$15,726
Lurasidone Hcl27$14,454
XanaxAlprazolam12$11,000
SunosiSolriamfetol Hcl12$10,552
Clozapine62$3,698
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl34$2,212
Clozapine OdtClozapine14$2,067
Aripiprazole22$1,922
Venlafaxine Hcl ErVenlafaxine Hcl49$1,764
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$1,366
Duloxetine Hcl19$1,166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$32$66,97431 claims
AbbVieVraylar$401$35,78615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →